Ultralife (ULBI) Stock Price
Ultralife Price
Revenue has compounded at 3.8% per year over the past 19 years to 191.16 M USD. Earnings per share have grown at 1.0% per year over the last 17 years. Ultralife's net margin stands at -3.1%, down from -0.2% several years earlier. Analysts set a median price target of 14.28 USD, implying 175.1% above the current price. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus. The stock trades about 3% above its 52-week low.
Ultralife stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Ultralife over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Ultralife stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Ultralife's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Ultralife Price |
|---|---|
| 7/31/2026 | 5.19 USD |
| 7/30/2026 | 5.16 USD |
| 7/29/2026 | 5.35 USD |
| 7/27/2026 | 5.54 USD |
| 7/23/2026 | 5.38 USD |
| 7/22/2026 | 5.45 USD |
| 7/21/2026 | 5.44 USD |
| 7/20/2026 | 5.27 USD |
| 7/17/2026 | 5.51 USD |
| 7/16/2026 | 5.55 USD |
| 7/15/2026 | 5.75 USD |
| 7/14/2026 | 5.66 USD |
| 7/13/2026 | 5.86 USD |
| 7/10/2026 | 5.85 USD |
| 7/9/2026 | 5.81 USD |
| 7/8/2026 | 5.88 USD |
| 7/7/2026 | 5.98 USD |
| 7/6/2026 | 6.17 USD |
| 7/2/2026 | 6.12 USD |
| 7/1/2026 | 6.26 USD |
| 6/30/2026 | 6.32 USD |
| 6/29/2026 | 6.03 USD |
| 6/26/2026 | 6.19 USD |
| 6/25/2026 | 6.23 USD |
| 6/24/2026 | 6.23 USD |
| 6/23/2026 | 6.16 USD |
| 6/22/2026 | 6.35 USD |
| 6/18/2026 | 6.46 USD |
| 6/17/2026 | 6.29 USD |
| 6/16/2026 | 6.41 USD |
| 6/15/2026 | 6.60 USD |
| 6/12/2026 | 6.58 USD |
| 6/11/2026 | 6.50 USD |
| 6/10/2026 | 6.48 USD |
| 6/9/2026 | 6.49 USD |
| 6/8/2026 | 6.66 USD |
| 6/5/2026 | 6.69 USD |
| 6/4/2026 | 6.94 USD |
| 6/3/2026 | 6.91 USD |
| 6/2/2026 | 7.11 USD |
| 6/1/2026 | 7.26 USD |
| 5/29/2026 | 7.25 USD |
| 5/28/2026 | 7.76 USD |
| 5/27/2026 | 7.75 USD |
| 5/26/2026 | 6.86 USD |
| 5/22/2026 | 6.44 USD |
| 5/21/2026 | 6.28 USD |
| 5/20/2026 | 5.99 USD |
| 5/19/2026 | 6.00 USD |
| 5/18/2026 | 6.10 USD |
| 5/15/2026 | 6.07 USD |
| 5/14/2026 | 6.10 USD |
| 5/13/2026 | 5.88 USD |
| 5/12/2026 | 5.91 USD |
| 5/11/2026 | 6.13 USD |
| 5/8/2026 | 5.97 USD |
| 5/6/2026 | 6.74 USD |
| 5/5/2026 | 6.83 USD |
| 4/23/2026 | 7.78 USD |
| 4/22/2026 | 7.65 USD |
| 4/21/2026 | 7.76 USD |
| 4/20/2026 | 7.95 USD |
| 4/17/2026 | 7.74 USD |
| 4/16/2026 | 7.48 USD |
| 4/15/2026 | 7.38 USD |
| 4/14/2026 | 7.47 USD |
| 4/13/2026 | 7.01 USD |
| 4/10/2026 | 6.80 USD |
| 4/9/2026 | 6.85 USD |
| 4/8/2026 | 6.84 USD |
| 4/7/2026 | 6.74 USD |
| 4/6/2026 | 6.74 USD |
| 4/2/2026 | 6.68 USD |
| 4/1/2026 | 6.59 USD |
| 3/31/2026 | 6.52 USD |
| 3/30/2026 | 6.13 USD |
| 3/27/2026 | 6.38 USD |
| 3/26/2026 | 6.61 USD |
| 3/25/2026 | 6.79 USD |
| 3/24/2026 | 6.43 USD |
| 3/23/2026 | 6.55 USD |
| 3/20/2026 | 6.43 USD |
| 3/19/2026 | 6.75 USD |
| 3/18/2026 | 6.72 USD |
| 3/17/2026 | 6.93 USD |
| 3/16/2026 | 7.01 USD |
| 3/13/2026 | 6.55 USD |
| 3/12/2026 | 6.06 USD |
| 3/11/2026 | 5.88 USD |
| 3/10/2026 | 5.73 USD |
| 3/9/2026 | 5.33 USD |
| 3/6/2026 | 5.25 USD |
| 3/5/2026 | 5.27 USD |
| 3/4/2026 | 5.55 USD |
| 3/3/2026 | 5.61 USD |
| 3/2/2026 | 5.86 USD |
| 2/27/2026 | 5.67 USD |
| 2/26/2026 | 5.80 USD |
| 2/25/2026 | 5.89 USD |
| 2/24/2026 | 5.81 USD |
| 2/23/2026 | 5.81 USD |
| 2/20/2026 | 5.87 USD |
| 2/19/2026 | 5.86 USD |
| 2/18/2026 | 6.03 USD |
| 2/17/2026 | 6.22 USD |
| 2/13/2026 | 6.42 USD |
| 2/12/2026 | 6.26 USD |
| 2/11/2026 | 6.35 USD |
| 2/10/2026 | 6.34 USD |
| 2/9/2026 | 6.53 USD |
| 2/6/2026 | 6.34 USD |
| 2/5/2026 | 6.31 USD |
| 2/4/2026 | 6.73 USD |
| 2/3/2026 | 6.59 USD |
| 2/2/2026 | 6.49 USD |
| 1/30/2026 | 6.38 USD |
| 1/29/2026 | 6.47 USD |
| 1/28/2026 | 6.40 USD |
| 1/27/2026 | 6.36 USD |
| 1/26/2026 | 6.20 USD |
| 1/23/2026 | 6.38 USD |
| 1/22/2026 | 6.31 USD |
| 1/21/2026 | 6.57 USD |
| 1/20/2026 | 6.51 USD |
| 1/16/2026 | 6.63 USD |
| 1/15/2026 | 7.04 USD |
| 1/14/2026 | 6.24 USD |
| 1/13/2026 | 6.30 USD |
| 1/12/2026 | 6.26 USD |
| 1/9/2026 | 5.88 USD |
| 1/8/2026 | 6.18 USD |
| 1/7/2026 | 5.99 USD |
| 1/6/2026 | 5.78 USD |
| 1/5/2026 | 5.98 USD |
| 1/2/2026 | 5.65 USD |
| 12/31/2025 | 5.72 USD |
| 12/30/2025 | 5.55 USD |
| 12/29/2025 | 5.61 USD |
| 12/26/2025 | 5.76 USD |
| 12/24/2025 | 5.91 USD |
| 12/23/2025 | 5.85 USD |
| 12/22/2025 | 5.92 USD |
| 12/19/2025 | 5.74 USD |
| 12/18/2025 | 5.80 USD |
| 12/17/2025 | 5.91 USD |
| 12/16/2025 | 5.79 USD |
| 12/15/2025 | 5.75 USD |
| 12/12/2025 | 5.75 USD |
| 12/11/2025 | 5.77 USD |
| 12/10/2025 | 5.54 USD |
| 12/9/2025 | 5.45 USD |
| 12/8/2025 | 5.40 USD |
| 12/5/2025 | 5.65 USD |
| 12/4/2025 | 5.56 USD |
| 12/3/2025 | 5.65 USD |
| 12/2/2025 | 5.54 USD |
| 12/1/2025 | 5.56 USD |
| 11/28/2025 | 5.69 USD |
| 11/26/2025 | 5.80 USD |
| 11/25/2025 | 5.87 USD |
| 11/24/2025 | 5.64 USD |
| 11/21/2025 | 5.24 USD |
| 11/20/2025 | 5.17 USD |
| 11/19/2025 | 5.06 USD |
| 11/18/2025 | 5.05 USD |
| 11/17/2025 | 5.54 USD |
| 11/14/2025 | 5.56 USD |
| 11/13/2025 | 5.74 USD |
| 11/12/2025 | 5.76 USD |
| 11/11/2025 | 5.66 USD |
| 11/10/2025 | 6.24 USD |
| 11/7/2025 | 6.75 USD |
| 11/6/2025 | 6.87 USD |
| 11/5/2025 | 7.01 USD |
| 11/4/2025 | 6.86 USD |
| 11/3/2025 | 6.95 USD |
| 10/31/2025 | 7.03 USD |
| 10/30/2025 | 6.86 USD |
| 10/29/2025 | 6.86 USD |
| 10/28/2025 | 6.97 USD |
| 10/27/2025 | 6.76 USD |
| 10/24/2025 | 6.95 USD |
| 10/23/2025 | 6.74 USD |
| 10/22/2025 | 6.65 USD |
| 10/21/2025 | 6.83 USD |
| 10/20/2025 | 6.71 USD |
| 10/17/2025 | 6.44 USD |
| 10/16/2025 | 6.82 USD |
| 10/15/2025 | 7.06 USD |
| 10/14/2025 | 7.21 USD |
| 10/13/2025 | 6.92 USD |
| 10/10/2025 | 6.41 USD |
| 10/9/2025 | 6.81 USD |
| 10/8/2025 | 6.84 USD |
| 10/7/2025 | 6.69 USD |
| 10/6/2025 | 7.08 USD |
| 10/3/2025 | 6.87 USD |
| 10/2/2025 | 6.81 USD |
| 10/1/2025 | 6.84 USD |
| 9/30/2025 | 6.82 USD |
| 9/29/2025 | 6.83 USD |
| 9/26/2025 | 6.81 USD |
| 9/25/2025 | 6.83 USD |
| 9/24/2025 | 7.02 USD |
| 9/23/2025 | 6.90 USD |
| 9/22/2025 | 7.06 USD |
| 9/19/2025 | 7.06 USD |
| 9/18/2025 | 7.14 USD |
| 9/17/2025 | 6.84 USD |
| 9/16/2025 | 6.77 USD |
| 9/15/2025 | 6.83 USD |
| 9/12/2025 | 6.85 USD |
| 9/11/2025 | 6.95 USD |
| 9/10/2025 | 6.70 USD |
| 9/9/2025 | 6.57 USD |
| 9/8/2025 | 6.99 USD |
| 9/5/2025 | 7.12 USD |
| 9/4/2025 | 7.19 USD |
| 9/3/2025 | 6.75 USD |
| 9/2/2025 | 7.00 USD |
| 8/29/2025 | 6.95 USD |
| 8/28/2025 | 6.89 USD |
| 8/27/2025 | 6.90 USD |
| 8/26/2025 | 6.95 USD |
| 8/25/2025 | 6.93 USD |
| 8/22/2025 | 7.21 USD |
| 8/21/2025 | 6.66 USD |
| 8/20/2025 | 6.60 USD |
| 8/19/2025 | 6.65 USD |
| 8/18/2025 | 6.60 USD |
| 8/15/2025 | 6.51 USD |
| 8/14/2025 | 6.65 USD |
| 8/13/2025 | 6.85 USD |
| 8/12/2025 | 6.86 USD |
| 8/11/2025 | 6.80 USD |
| 8/8/2025 | 6.59 USD |
| 8/7/2025 | 6.77 USD |
| 8/6/2025 | 8.16 USD |
| 8/5/2025 | 8.23 USD |
| 8/4/2025 | 8.20 USD |
Ultralife Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Ultralife Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 139.00 | 101.00 | 78.00 | 66.00 | 76.00 | 82.00 | 85.00 | 87.00 | 106.00 | 107.00 | 98.00 | 131.00 | 158.00 | 164.00 | 191.00 | 224.00 |
| -21.91 | -27.34 | -22.77 | -15.38 | 15.15 | 7.89 | 3.66 | 2.35 | 21.84 | 0.94 | -8.41 | 33.67 | 20.61 | 3.80 | 16.46 | 17.28 |
| 25.18 | 27.72 | 28.21 | 28.79 | 30.26 | 30.49 | 30.59 | 28.74 | 29.25 | 27.10 | 24.49 | 22.14 | 24.68 | 25.61 | 23.04 | 23.04 |
| 35.00 | 28.00 | 22.00 | 19.00 | 23.00 | 25.00 | 26.00 | 25.00 | 31.00 | 29.00 | 24.00 | 29.00 | 39.00 | 42.00 | 44.00 | 51.60 |
| 2.00 | – | – | -1.00 | 3.00 | 3.00 | 6.00 | 6.00 | 7.00 | 6.00 | – | – | 9.00 | 9.00 | 9.00 | -3.00 |
| 1.44 | – | – | -1.52 | 3.95 | 3.66 | 7.06 | 6.90 | 6.60 | 5.61 | – | – | 5.70 | 5.49 | 4.71 | -1.34 |
| -2.00 | -1.00 | – | -2.00 | 2.00 | 3.00 | 7.00 | 24.00 | 5.00 | 5.00 | – | – | 7.00 | 6.00 | -5.00 | 14.00 |
| -66.67 | -50.00 | – | – | -200.00 | 50.00 | 133.33 | 242.86 | -79.17 | – | – | – | – | -14.29 | -183.33 | -380.00 |
| 17.36 | 17.44 | 17.57 | 17.51 | 15.76 | 15.36 | 16.03 | 16.29 | 16.21 | 16.12 | 16.08 | 16.14 | 16.48 | 16.63 | 16.65 | 16.65 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Ultralife generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Ultralife retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Ultralife's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Ultralife has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Ultralife's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Ultralife stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Ultralife Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Ultralife business model & stock analysis
Ultralife SWOT Analysis
Strengths
Ultralife Corp has a strong market presence and brand recognition.
The company offers high-quality and innovative products, giving it a competitive edge.
Ultralife Corp has a diverse product portfolio, catering to various industries and customer segments.
Weaknesses
The company is highly dependent on a few key customers, which poses a risk to its revenue stream.
Ultralife Corp has limited global reach, primarily focusing on certain geographic regions.
The company faces increasing competition from both established players and emerging startups.
Opportunities
Ultralife Corp can expand its market presence by targeting untapped emerging markets.
The growing demand for renewable energy solutions presents an opportunity for the company to expand its product offerings.
Strategic partnerships and collaborations can help Ultralife Corp enter new markets or enhance its current offerings.
Threats
The ongoing trade disputes and tariffs can impact Ultralife Corp's international operations and supply chain.
Rapid technological advancements can render some of Ultralife Corp's products obsolete, requiring continuous innovation.
Changes in government regulations and policies may affect the company's operations and market opportunities.
Ultralife Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
Ultralife Segments
Ultralife Revenue by Segment (1/5)
3 Years
5 Years
Max
Details
Ultralife Revenue by Segment (2/5)
3 Years
5 Years
Max
Details
Ultralife Revenue by Segment (3/5)
3 Years
5 Years
Max
Details
Ultralife Revenue by Segment (4/5)
3 Years
5 Years
10 Years
Max
Details
Ultralife Revenue by Segment (5/5)
3 Years
5 Years
10 Years
Max
Details
Ultralife Revenue by Region
3 Years
5 Years
Max
Details
Ultralife Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Ultralife historical P/E ratio, EBIT multiple, and P/S ratio
Ultralife annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Ultralife shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Ultralife forecasts and price targets in August 2026
Analyst Price Targets 2026Ultralife Analyst Rating Actions
| Date | Firm | Action | Rating | Reliability |
|---|---|---|---|---|
| 11/15/2024 | Maintained | Buy | 71 | |
| 6/27/2024 | Maintained | Buy | 71 | |
| 3/5/2024 | Maintained | Buy | 71 | |
| 8/8/2023 | Maintained | Buy | 71 | |
| 5/2/2013 | Downgrade | HoldReduce | – |
Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.
Ultralife Earnings Calls
Ultralife Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 8/5/2026 | 0.21USD | - | 56.10 MUSD | - | 2026 Q2 |
| 5/7/2026 | 0.16USD | - | 53.45 MUSD | - | 2026 Q1 |
| 3/10/2026 | 0.28USD | - | 58.14 MUSD | - | 2025 Q4 |
| 11/18/2025 | 0.22USD | - | 54.06 MUSD | - | 2025 Q3 |
| 8/7/2025 | 0.14USD | - | 52.02 MUSD | - | 2025 Q2 |
| 4/25/2024 | 0.10USD | - | 38.76 MUSD | - | 2024 Q1 |
| 2/29/2024 | 0.09USD | - | 39.78 MUSD | - | 2023 Q4 |
| 7/26/2023 | 0.15USD | - | 34.00 MUSD | - | 2023 Q2 |
| 4/26/2023 | 0.03USD | - | 30.45 MUSD | - | 2023 Q1 |
| 2/1/2023 | 0.09USD | - | 37.56 MUSD | - | 2022 Q4 |
EESG©
Eulerpool ESG Scorecard© for the Ultralife stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Ultralife shareholder structure
| % | Name |
|---|---|
6.55094% | |
6.01288% | |
3.08613% | |
3.05132% | |
1.50222% | |
1.35200% |
Ultralife Beneficial Ownership Filings (SEC 13D/G)
| Stake | Holder | Filing |
|---|---|---|
39.60% | SEC ↗ | |
38.40% | SEC ↗ | |
38.40% | SEC ↗ | |
26.70% | SEC ↗ | |
15.70% | SEC ↗ | |
15.70% | SEC ↗ | |
10.98% | SEC ↗ | |
9.90% | SEC ↗ | |
9.90% | SEC ↗ | |
9.90% | SEC ↗ |
Ultralife Executives and Management Board
7 members · avg. age 63 · 29 % women
Mr. Michael Manna (54)
President, Chief Executive Officer, Director · since 2022
489,177.00 USD
Management
Mr. Philip Fain (69)
Chief Financial Officer, Treasurer, Secretary
Ms. Jody Burfening
Investor Relations · since 2020
Board of Directors
Mr. Bradford Whitmore (67)
Independent Chairman of the Board
Ms. Janie Goddard (53)
Independent Director
Mr. Thomas Saeli (67)
Independent Director
Mr. Robert Shaw (67)
Independent Director
Ultralife Supply Chain
Ultralife Supply Chain
Correlation: how closely stock prices move together
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | -0.31 | -0.24 | -0.04 |
Frequently asked questions about Ultralife
The business model of Ultralife Corp revolves around the design, manufacture, and distribution of power solutions, communications, and electronic systems. Ultralife Corp is a leading provider of both standard and customized battery and energy solutions for diverse applications in industries such as defense, medical, and industrial sectors. By offering innovative products and solutions, Ultralife Corp aims to meet the demands for reliable and long-lasting power sources. Leveraging its expertise in technology and engineering, Ultralife Corp consistently strives to provide cutting-edge solutions that enhance performance and ensure the efficient operation of electronic devices and systems.
Ultralife Corp is primarily active in the industries of defense and commercial industries.
The main competitors of Ultralife Corp in the market include companies like Energizer Holdings Inc., Duracell Inc., and Tadiran Electronic Industries Ltd. These companies also operate in the battery and energy products industry, making them direct competitors to Ultralife Corp. Energizer Holdings Inc. is a global leader in the industry, offering a wide range of battery solutions. Duracell Inc. is another major competitor known for its reliable and long-lasting batteries. Tadiran Electronic Industries Ltd. specializes in producing high-performance lithium batteries and power systems. As Ultralife Corp operates in a competitive market, these companies present challenges and opportunities for growth and market share.
Ultralife Corp is a renowned company operating in the field of advanced battery and energy products. Established in 1990, the company has accumulated an impressive history of providing innovative solutions to meet the power needs of various industries. With a strong focus on research and development, Ultralife Corp has continuously introduced cutting-edge technologies and garnered a reputation for delivering high-quality and reliable products. The company's commitment to excellence has enabled them to serve diverse sectors including defense, medical, and industrial. Ultralife Corp's extensive expertise and dedication to customer satisfaction make it a trusted leader in the industry.
Ultralife Corp has achieved several significant milestones throughout its history. One notable achievement is their successful acquisition of Accutronics Ltd in 2017, expanding their presence in the global market. They have also received various awards and recognitions, including the Frost & Sullivan 2019 Global Entrepreneurial Company of the Year in the military and aerospace battery market. Furthermore, Ultralife Corp has consistently demonstrated strong financial performance, with consistent revenue growth and improved profitability. These milestones reflect their commitment to innovation, market expansion, and delivering value to their shareholders.
Ultralife Corp is primarily present in various countries and regions globally. With their strong presence in North America, Ultralife Corp operates extensively in the United States and Canada. Additionally, they have expanded their operations in Europe, including countries like Germany, France, and the United Kingdom. Ultralife Corp also has a significant presence in Asia, particularly in China and Japan. Through their comprehensive network, Ultralife Corp ensures a widespread presence in key markets, allowing them to serve their clients efficiently and effectively on a global scale.
Ultralife Corp represents a commitment to excellence, innovation, and customer satisfaction. With a strong corporate philosophy focused on delivering superior quality products, Ultralife Corp strives to meet the needs of its customers through the development of technologically advanced solutions. By prioritizing cutting-edge research and development, Ultralife Corp aims to enhance the performance and reliability of its products, ensuring they meet the highest industry standards. With a customer-centric approach, Ultralife Corp values integrity, transparency, and continuous improvement, fostering strong relationships with its clients and partners. Through its dedication to these values, Ultralife Corp establishes itself as a trusted and leading provider in its industry.
Analysts currently set an average price target of 14.28 USD for the Ultralife stock (median: 14.28 USD), implying +175.1 % versus the latest price. The consensus is based on 7 analyst ratings.
7 analysts currently rate the Ultralife stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Ultralife to generate revenue of 224.90 M USD and earnings per share of 0.86 USD.
Converted at the current exchange rate, the Ultralife share trades at 4.51 EUR (5.19 USD).
The Ultralife share (ULBI) is listed on 4 stock exchanges, including: NASDAQ (ULBI), Frankfurt (ULB.F), München (ULB.MU), Düsseldorf (ULB.DU).
Ultralife Corporation is a leading company in the field of battery technology and offers innovative solutions for customers in the military, medical devices, industrial, and consumer applications sectors. The company was founded in 1990 and is headquartered in Newark, New York. Ultralife's products include primary and secondary batteries, chargers, accessories, and portable power supplies. They are also active in the identification systems and communication systems sectors, primarily developed for military applications. Ultralife offers a wide range of primary batteries suitable for various applications, including lithium-thionyl chloride batteries, lithium-manganese dioxide batteries, and alkaline batteries. These batteries are popular in military and other applications requiring long operating times. Ultralife's secondary batteries include nickel-cadmium, nickel-metal hydride, and lithium-ion batteries. These batteries are used primarily for portable devices, medical devices, and industrial applications. Ultralife also provides customized portable power supplies tailored to customer requirements. They are also active in the identification systems sector, offering various products such as RFID readers, writing modules, and transponders. These systems are mainly used for military applications but also for civilian applications such as access control and inventory management. In the communication systems sector, Ultralife offers various products including antennas, amplifiers, and high-frequency power amplifiers. These products are designed for military applications and civilian applications such as mobile communications, satellite communication, and wireless networks. Ultralife also has a division for custom solutions, where customized power supplies are designed to meet specific customer requirements and needs. Ultralife has an experienced design team that supports customers in developing products that meet their requirements. The business model of Ultralife is focused on meeting the needs of customers in various industries. The company is able to offer customized solutions to customers by providing a wide range of products including primary and secondary batteries, chargers, portable power supplies, identification systems, and communication systems. Ultralife focuses on quality and customer satisfaction. The company has implemented strict quality control procedures to ensure that its products meet customer requirements. Over the years, Ultralife has gained many satisfied customers and has established itself as a reliable provider of advanced technology. In summary, Ultralife's business model is focused on providing high-quality battery technology solutions that meet the needs of customers in various industries. They are also active in the identification systems and communication systems sectors, offering customized solutions to meet specific customer requirements. The company focuses on quality and customer satisfaction and has established itself as a reliable provider of advanced technology.
The expected revenue of Ultralife is 224.90 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Ultralife is 14.31 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Ultralife is currently 6.04. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Ultralife stock.
The price-to-sales ratio (P/S) of Ultralife is currently 0.38. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Ultralife stock.
The Eulerpool Quality Score for Ultralife is 4/10.
The ISIN of Ultralife is US9038991025. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Ultralife is 888615. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Ultralife is ULBI. The ticker symbol is used to trade Ultralife shares on the stock exchange.
Ultralife paid dividends every year for the past 0 years.
Ultralife is assigned to the 'Industry' sector.
The dividends of Ultralife are distributed in USD.
Ultralife stock
Ultralife Peer Group
Ultralife Ticker
Ultralife FIGI
All fundamentals and in-depth analysis of Ultralife
Our stock analysis for Ultralife stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ultralife. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.